Columnist Oluwatosin Adesoye reflects on her thriving life as she turns 38 (and counting) with sickle cell disease.

Enlargement of the heart’s left upper chamber in sickle cell patients is associated with worse disease severity, per a new ...

Wilson explains how Pfizer's decision to withdraw Oxbryta from global markets could affect the sickle cell community.

The U.K.'s Black History Month presents an opportunity for sickle cell patients to combat false narratives, columnist Mary ...

Columnist Sylvia Amuta always told other caregivers that it's OK to take a break. But sometimes things are easier said than ...

Mitem Pharma acquired from Novartis worldwide rights to Desferal, commonly used to lower excessive iron levels induced by ...

Preschool-aged children with sickle cell disease with limited access to healthy food and transportation are at higher risk ...

Columnist Mary Shaniqua, returning from her post-wedding activities, has learned that stepping back from advocacy obligations ...

Here in the U.K., October is Black History Month, and this year’s theme is “reclaiming narratives.” I believe that theme is particularly apt for sickle cell patients. People with sickle cell disease ...

The stroke rate among adults and children with sickle cell disease in the U.S. is rising, indicating a need for greater ...

Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.